Close Menu

NEW YORK (GenomeWeb News) – Shares of Sequenom dropped more than 28 percent in the July, making it the biggest mover among firms in the GenomeWeb Daily News Index during the month.

Overall, the index, comprising 30 companies in the omics tools and molecular diagnostics space, was up about 5 percent in July compared to June. It beat the Dow Jones Industrial Average, which was up 4 percent for the month, but trailed the Nasdaq, which was up 7 percent, and the Nasdaq Biotech Index which gained 14 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.